Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.72, denoting a -6.7% move from the preceding trading day.
HIMS expands into Australia's women's healthcare market with the Hers launch, offering personalized treatments for weight, hormonal health and hair regrowth.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 500 | $28,360 | $13,775 | -$14,585 | -51.43% |
Curtis Ellergodt Rothschild Investment LLC | 251 | $8,032.26 | $6,957.72 | -$1,074.54 | -13.38% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 337,688 | $11.71M | $9.36M | -$2.35M | -20.05% |
Means Investment Company Means Investment Company Inc. | 7,166 | $173,273.88 | $208,888.9 | $35,615.02 | 20.55% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 13,410 | $499,065.04 | $371,725.2 | -$127,339.84 | -25.52% |
| Health Care Providers & Services Industry | Healthcare Sector | Andrew Dudum CEO | NYSE Exchange | 433000106 CUSIP |
| US Country | 2,442 Employees | - Last Dividend | - Last Split | 13 Sep 2019 IPO Date |
Hims & Hers Health, Inc., based in San Francisco, California, operates as a telehealth platform connecting consumers with licensed healthcare professionals across the United States, the United Kingdom, and other international locations. The company leverages its websites and mobile application to offer a variety of carefully selected health and wellness products and services, both on prescription and over-the-counter basis. Its business model focuses on providing convenient access to ongoing healthcare services, including prescription medication refills and consultations with healthcare providers, as well as a wide range of wellness products through direct sales and wholesale partnerships.